Skip to content

Joel Ojeda-Rivera

NPI 1275706194ActiveIndividual· Internal Medicine, Rheumatology· Arecibo, PR

Internal Medicine, Rheumatology in Arecibo, Puerto Rico, licensed in PR, with an NPI issued in April 2008. Part D covered 5,482 prescriptions written in 2024, 87% of them generic. Glaxosmithkline, LLC. reported $14.11 in payments in 2025, mostly food and beverage.

Overview

NPI1275706194
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedApr 11, 2008
Last updated in NPPESJul 10, 2014

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Rheumatology Primary207RR0500X18373PR
Internal Medicine207R00000X18373PR

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (PR)

Part D prescriptions in 2024

Prescriptions (claims)5,482 · 6,061 30-day fills
Patients973
Total drug cost$2,952,238
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$14.11 · 1 payment from 1 company
  • 2024$116.15 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Glaxosmithkline, LLC.$14.111

What the 2025 payments were for

  • Food and Beverage$14.11 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records